ReviewHematology. American Society of Hematology. Education Program2018
The argument for using imatinib in CML.
Simone Claudiani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papercites it
ReviewHematology. American Society of Hematology. Education Program2018
Simone Claudiani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.